WhichRecall
Class IIReported 2025-12-31

Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03

Recalled by Merck Sharp & Dohme LLC

Reason for Recall

Presence of particulate matter: potential presence of metal particulates in the product.

Advertisement
Recall Number
D-0241-2026
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-12-12
Reported
2025-12-31
Distribution
Nationwide in the USA
Code Info
Lot #: Z014503, Exp 11/15/2027
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement